Administration of a CD31-derived peptide delays the onset and significantly increases survival from lethal graft-versus-host disease (Q73063987)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 February 1997
edit
Language Label Description Also known as
English
Administration of a CD31-derived peptide delays the onset and significantly increases survival from lethal graft-versus-host disease
scientific article published on 01 February 1997

    Statements

    Administration of a CD31-derived peptide delays the onset and significantly increases survival from lethal graft-versus-host disease (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit